Despite the policy risks, AbbVie delivered a strong first quarter, posting adjusted earnings per share of $2.46, $0.10 above ...

Investing.com -- HSBC upgraded Keurig Dr Pepper (NASDAQ: KDP) to Buy from Hold and raised its target price to $42 from $36, ...

P&G faced a tougher-than-expected recent quarter due to a global economic slowdown, retailers cutting back on inventory, and ...

Investing.com -- Biohaven Pharma (NYSE: BHVN) shares fell sharply by as much as 21% as the company withdrew its marketing authorization application for Dazluma in Europe, intended to treat ...

Investing.com -- KeyBanc Capital Markets has upgraded Lowe’s (NYSE: LOW) and Williams-Sonoma (NYSE: WSM) to Overweight from ...